Cardiovascular
Page 1 • 3 itemsAccess global pharma market insights on cardiovascular drug development, clinical trials, regulatory approvals, and M&A activity. Stay ahead.
CVRx Enrolls First Patient in BENEFIT-HF Heart Failure Trial Testing Barostim Device
CVRx begins landmark BENEFIT-HF clinical trial for Barostim neuromodulation device in expanded heart failure patient population at Avera Heart Hospital.
SQ Innovation's Lasix ONYU Subcutaneous Heart Failure Trial Results to Be Presented at Heart Failure 2026
SQ Innovation announces SUBCUT HF II trial results for Lasix ONYU, the first at-home subcutaneous furosemide treatment for heart failure edema, May 9th.
Getinge Receives CE Mark for Cardiohelp II ECLS System and EU MDR Approval for Intergard Synergy Vascular Graft
Getinge AB achieves major regulatory milestones with CE mark for Cardiohelp II ECLS system and EU MDR approval for Intergard Synergy antimicrobial vascular graft.